The study sought to examine whether someone inoculated could still acquire the virus without getting sick and spread it to others
Multiple countries have advised against administering the Oxford-AstraZeneca vaccine to the elderly population.
There is hard evidence that fractional doses and delayed doses have worked when doctors have tried them out of desperation.
Increasing antibiotic resistance already causes 1.5 million excess deaths each year, the University of Oxford has said.
Flights ferry COVID-19 vaccine to 13 cities ahead of roll out on 16 Jan; preparations on track, says health ministry
India on Tuesday recorded 12,584 new cases of coronavirus, the lowest in around seven months, taking the country's COVID-19 caseload to1,04,79,179, as per the Union health ministry's morning update
SII, Bharat Biotech engage in war of words: A look at controversies surrounding vaccines cleared by DCGI
The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India took place after the DCGI announced the approval of the Covaxin and Covishield vaccines
The approval by Medicines and Healthcare products Regulatory Agency (MHRA) means the vaccine is both safe and effective
The study published in the Lancet showed the vaccine had an efficacy of 62 percent for those given two full doses, and of 90 percent in those given a half and then a full dose
The phase-three clinical trial of the Oxford COVID-19 vaccine is being conducted by the SII, and is being co-sponsored by the ICMR
COVID-19 vaccine Covaxin phase-3 trial starts at AIIMS-Delhi; actively considering night curfew, AAP govt tells HC
With 44,489 more testing positive in a day, India's coronavirus caseload on Thursday increased to 92,66,705 while the toll mounted to 1,35,223 with 524 new fatalities, said the Union health ministry.
The health minster said that no state will be given preferential treatment and the distribution of vaccines will be equitable.
I wondered — did I actually get the vaccine? Three days of internet searches about "vaccine injection site," "muscle pain" and other terms got me nowhere.
COVID-19 vaccine 90% effective in early analysis, claims Pfizer; 'life could return to normal by Spring', says UK govt adviser
Sir John Bell, a professor at Oxford University and also a member of the UK government's vaccine task force, answered in the affirmative when asked whether life will return to normal by spring
In the fifth episode of 'Sunday Samvaad', the health minister also said the decision on emergency use authorisation for vaccines against the virus will depend on results of the clinical trials
Coronavirus Vaccine Tracker: Serum Institute of India pauses clinical trials after DCGI show-cause notice
The Pune-based company said that it's reviewing the situation and pausing India trials of the COVID-19 vaccine candidate till AstraZeneca restarts the trials
Phase II human trial of Oxford's COVID-19 vaccine begins at Pune hospital; 32-year-old administered the first shot
Doctors administered the first shot of 'Covishield' after tests related to COVID-19 and antibodies came negative, officials said
Coronavirus updates: Karnataka minister BC Patil tests COVID-19 positive; 5,483 new cases in state today
Coronavirus LIVE updates: The Sikkim government on Friday extended the complete lockdown in the state till 3 August in view of a spurt in COVID-19 cases, a senior official said.
Notes from a pandemic: On the shared experience of COVID-19, and the significance of mundane little pleasures
For the first time in our lifetimes, we have a single reference point that our entire planet’s human inhabitants can relate to
Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.
Oxford University COVID-19 vaccine produces strong antibodies; T-cell response seen till day 56, show initial results
Scientists said that they found that their experimental COVID-19 vaccine produced a dual immune response that lasted at least two months.